Cargando…
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes
Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes severe hepatitis, with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we study the impact of HDV on viral antigen processing and presentation. Us...
Autores principales: | Tham, Christine Y.L., Kah, Janine, Tan, Anthony T., Volz, Tassilo, Chia, Adeline, Giersch, Katja, Ladiges, Yvonne, Loglio, Alessandro, Borghi, Marta, Sureau, Camille, Lampertico, Pietro, Lütgehetmann, Marc, Dandri, Maura, Bertoletti, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659593/ https://www.ncbi.nlm.nih.gov/pubmed/33205065 http://dx.doi.org/10.1016/j.xcrm.2020.100060 |
Ejemplares similares
-
Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice
por: Giersch, Katja, et al.
Publicado: (2021) -
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
por: Giersch, Katja, et al.
Publicado: (2015) -
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition
por: Dandri, Maura, et al.
Publicado: (2021) -
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
por: Giersch, Katja, et al.
Publicado: (2023) -
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017)